Basic/Clinical Science Session
Best of the Journal of the American Medical Association and the New England Journal of Medicine
November 07, 2025 | 02:00 PM - 04:00 PM
Location: Grand Ballroom A, Convention Center
Session Description
This inaugural session highlights the most impactful kidney research articles that have been recently published in these prestigious journals. To provide current information, the list of presentations will be available in September.
Note: Continuing education credits are not being offered for this session.
ASN thanks JAMA and NEJM for assistance with this session.
Learning Objective(s)
- Discuss high-impact research published in JAMA
- Discuss high-impact research published in NEJM
Learning Pathway(s)
- Other
Moderators
Presentations
- JAMA: Lorundrostat in Participants with Uncontrolled Hypertension and Treatment-Resistant Hypertension - The Launch-HTN Randomized Clinical Trial
02:00 PM - 02:20 PM
- NEJM: Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
02:20 PM - 02:40 PM
- JAMA: Dialysis Facility Staffing Ratios and Kidney Transplant Access Among Adolescents and Young Adults
02:40 PM - 03:00 PM
- NEJM: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
03:00 PM - 03:20 PM
- JAMA: Discordance in Creatinine Based eGFR and Cystatin C Based eGFR and Clinical Outcomes - A Meta-Analysis
03:20 PM - 03:40 PM
- NEJM: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
03:40 PM - 04:00 PM